Summary
The core message of the session is that Abu Dhabi is positioning life sciences—and especially healthy longevity—as an investable opportunity by combining data, incentives, regulation, physical infrastructure, and public-sector orchestration. The moderator opened by framing the discussion for an investor audience: what Abu Dhabi has built, why life sciences are investable there, and where longevity-related opportunities may be underappreciated. Dr. Mohammed Bitar described Abu Dhabi’s vision as an ecosystem for healthcare, life sciences growth, and innovation, with longevity at its center. He highlighted HELM, an initiative with the Abu Dhabi Investment Office and the Department of Health, Abu Dhabi, standing for health, endurance, longevity, and medicine, designed to attract investors, researchers, and innovators.
Key Topics
5 key topics from Georgia Tolley, Mohammed Bitar and Vladislav Boutenko at LIVEX | Investor Stage. Thicker branches were mentioned more often in the talk.
Key Takeaways
- Use population-scale data to strengthen life-sciences investment cases.
- Target health span, not only longer lifespan, when evaluating longevity opportunities.
- Assess city infrastructure as part of longevity investment potential.
- Leverage Abu Dhabi’s incentives, regulation, and labs to reduce startup costs.
- Build early-life prevention strategies to improve long-term healthy aging outcomes.
“data, our science is following the data, and capital is following the science.”
Up Next
Next in agenda
Making Districts, Making Markets: Industrial and Innovation Real Assets
Also on abu dhabi
The UHNW Economy: Wellness, Hospitality and Luxury as Asset Classes
Also on abu dhabi